Swiss ETP issuer 21Shares AG said on Wednesday that the Financial Conduct Authority had approved Supplement No. 1 to its base prospectus dated 21 April 2026 for the company’s Exchange Traded Products Programme.
The supplement is available for viewing and will be submitted to the FCA’s Electronic Submission Service, a notice published via GlobeNewswire said. It may shortly appear on the National Storage Mechanism.
The filing updates compliance and disclosure materials and does not launch a product or change fundraising terms. It keeps the programme’s documentation current for future issuance.
Programme context
The underlying UK base prospectus, dated 8 May 2025, sets out a framework under which 21Shares AG may issue exchange traded products from time to time. Products under the programme are expected to be traded on the Main Market of the London Stock Exchange in its professional investors only segment, and they must not be sold or distributed to retail clients in the United Kingdom.
As of the 2025 base prospectus, Bitcoin and Ether were the only crypto assets that the London Stock Exchange had approved for listing under the programme.
21Shares AG is incorporated in Switzerland and, as of November 2025, is a wholly owned subsidiary within the FalconX Holdings Limited group.
